No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪11.34 B‬EUR
‪357.60 M‬EUR
‪3.67 B‬EUR
‪39.79 M‬
Beta (1Y)


Pierre Boulud
Marcy l'Etoile
Employees (FY)
‪14.65 K‬
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.
Revenue to profit conversion
Debt level and coverage
Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BIM is 95.90 EUR — it has decreased by 0.10% in the past 24 hours. Watch BIOMERIEUX stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange BIOMERIEUX stocks are traded under the ticker BIM.
BIM stock has fallen by 3.62% compared to the previous week, the month change is a 2.14% fall, over the last year BIOMERIEUX has showed a 2.62% decrease.
We've gathered analysts' opinions on BIOMERIEUX future price: according to them, BIM price has a max estimate of 128.00 EUR and a min estimate of 90.00 EUR. Watch BIM chart and read a more detailed BIOMERIEUX stock forecast: see what analysts think of BIOMERIEUX and suggest that you do with its stocks.
BIM reached its all-time high on Oct 14, 2020 with the price of 144.80 EUR, and its all-time low was 0.00 EUR and was reached on Feb 26, 2003. View more price dynamics on BIM chart.
See other stocks reaching their highest and lowest prices.
BIM stock is 1.84% volatile and has beta coefficient of 1.07. Track BIOMERIEUX stock price on the chart and check out the list of the most volatile stocks — is BIOMERIEUX there?
Today BIOMERIEUX has the market capitalization of ‪11.33 B‬, it has decreased by 3.52% over the last week.
Yes, you can track BIOMERIEUX financials in yearly and quarterly reports right on TradingView.
BIOMERIEUX is going to release the next earnings report on Sep 4, 2024. Keep track of upcoming events with our Earnings Calendar.
BIM net income for the last quarter is ‪196.00 M‬ EUR, while the quarter before that showed ‪161.60 M‬ EUR of net income which accounts for 21.29% change. Track more BIOMERIEUX financial stats to get the full picture.
Yes, BIM dividends are paid annually. The last dividend per share was 0.85 EUR. As of today, Dividend Yield (TTM)% is 0.89%. Tracking BIOMERIEUX dividends might help you take more informed decisions.
BIOMERIEUX dividend yield was 0.84% in 2023, and payout ratio reached 28.08%. The year before the numbers were 0.87% and 22.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 18, 2024, the company has ‪14.65 K‬ employees. See our rating of the largest employees — is BIOMERIEUX on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMERIEUX EBITDA is ‪795.10 M‬ EUR, and current EBITDA margin is 21.64%. See more stats in BIOMERIEUX financial statements.
Like other stocks, BIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMERIEUX stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOMERIEUX technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOMERIEUX stock shows the sell signal. See more of BIOMERIEUX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.